Yasuko Oguri

413 total citations
20 papers, 229 citations indexed

About

Yasuko Oguri is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Yasuko Oguri has authored 20 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Reproductive Medicine. Recurrent topics in Yasuko Oguri's work include TGF-β signaling in diseases (6 papers), S100 Proteins and Annexins (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). Yasuko Oguri is often cited by papers focused on TGF-β signaling in diseases (6 papers), S100 Proteins and Annexins (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). Yasuko Oguri collaborates with scholars based in Japan. Yasuko Oguri's co-authors include Makoto Saegusa, Ako Yokoi, Miki Hashimura, Toshihide Matsumoto, Mayu Nakagawa, Yoshio Kodera, Ryo Konno, Sabine Kajita, Yoshinori Hasegawa and Madoka Inukai and has published in prestigious journals such as PLoS ONE, Scientific Reports and American Journal Of Pathology.

In The Last Decade

Yasuko Oguri

20 papers receiving 226 citations

Peers

Countries citing papers authored by Yasuko Oguri

Since Specialization

Citations

This map shows the geographic impact of Yasuko Oguri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuko Oguri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuko Oguri more than expected).

Fields of papers citing papers by Yasuko Oguri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuko Oguri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuko Oguri. The network helps show where Yasuko Oguri may publish in the future.

Co-authorship network of co-authors of Yasuko Oguri

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuko Oguri. A scholar is included among the top collaborators of Yasuko Oguri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuko Oguri. Yasuko Oguri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	S100A4 contributes to colorectal carcinoma aggressive behavior and to chemoradiotherapy resistance in locally advanced rectal carcinoma 2024 ·Scientific Reports ·Yohei Harada, (unknown), (unknown), Yasuko Oguri, Miki Hashimura, Ako Yokoi, (unknown), Naomi K. Fukagawa, Misato Hayashi, (unknown), Chika Kusano, Hiroyuki Takahashi, Makoto Saegusa	2
2	Nucleobindin 2 inhibits senescence in gastric carcinoma 2024 ·Scientific Reports ·(unknown), Takashi Itoh, Yasuko Oguri, Miki Hashimura, Ako Yokoi, Toshihide Matsumoto, Yohei Harada, Naomi K. Fukagawa, Misato Hayashi, (unknown), Chika Kusano, Makoto Saegusa	2
3	EBP50 Depletion and Nuclear β-Catenin Accumulation Engender Aggressive Behavior of Colorectal Carcinoma through Induction of Tumor Budding 2023 ·Cancers ·(unknown), (unknown), Yasuko Oguri, Miki Hashimura, Ako Yokoi, Yohei Harada, Naomi K. Fukagawa, Misato Hayashi, (unknown), Chika Kusano, Makoto Saegusa	3
4	Nucleobindin-2 Mediates Transforming Growth Factor-β1–Driven Phenotypes in Zinc Finger E-Box Binding Homeobox 1–High Uterine Carcinosarcoma 2023 ·American Journal Of Pathology ·(unknown), Ako Yokoi, Miki Hashimura, Yasuko Oguri, Ryo Konno, Toshihide Matsumoto, (unknown), Mayu Nakagawa, (unknown), Takashi Ito, (unknown), Yohei Harada, Naomi K. Fukagawa, Yoshio Kodera, Makoto Saegusa	5
5	Anaplastic lymphoma kinase overexpression enhances aggressive phenotypic characteristics of endometrial carcinoma 2023 ·BMC Cancer ·Ako Yokoi, Yusaku Nakamura, Miki Hashimura, Yasuko Oguri, Toshihide Matsumoto, Mayu Nakagawa, (unknown), Takashi Ito, (unknown), (unknown), Naomi K. Fukagawa, Makoto Saegusa	1
6	Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma 2023 ·Molecular Oncology ·Mayu Nakagawa, Toshihide Matsumoto, Ako Yokoi, Miki Hashimura, Yasuko Oguri, Ryo Konno, (unknown), Takashi Ito, (unknown), Yohei Harada, Naomi K. Fukagawa, Yoshio Kodera, Makoto Saegusa	8
7	PTEN overexpression and nuclear β-catenin stabilization promote morular differentiation through induction of epithelial–mesenchymal transition and cancer stem cell-like properties in endometrial carcinoma 2022 ·Cell Communication and Signaling ·Ako Yokoi, (unknown), Miki Hashimura, Yasuko Oguri, Toshihide Matsumoto, Yoshinori Hasegawa, Mayu Nakagawa, (unknown), Takashi Ito, (unknown), (unknown), Naomi K. Fukagawa, Makoto Saegusa	10
8	A functional role of S100A4/non-muscle myosin IIA axis for pro-tumorigenic vascular functions in glioblastoma 2022 ·Cell Communication and Signaling ·(unknown), Ako Yokoi, (unknown), Miki Hashimura, Toshihide Matsumoto, Yasuko Oguri, Mayu Nakagawa, (unknown), Takashi Ito, Toshihiro Kumabe, Makoto Saegusa	8
9	Functional interaction between S100A1 and MDM2 may modulate p53 signaling in normal and malignant endometrial cells 2022 ·BMC Cancer ·Mayu Nakagawa, (unknown), Miki Hashimura, Yasuko Oguri, Toshihide Matsumoto, Ako Yokoi, (unknown), Takashi Ito, Makoto Saegusa	3
10	Anaplastic Lymphoma Kinase Overexpression Is Associated with Aggressive Phenotypic Characteristics of Ovarian High-Grade Serous Carcinoma 2021 ·American Journal Of Pathology ·Toshihide Matsumoto, (unknown), Yoshinori Hasegawa, Miki Hashimura, Yasuko Oguri, Hisako Inoue, Ako Yokoi, (unknown), Mayu Nakagawa, (unknown), Makoto Saegusa	12
11	Cytoplasmic EBP50 and elevated PARP1 are unfavorable prognostic factors in ovarian clear cell carcinoma 2021 ·Carcinogenesis ·Toshihide Matsumoto, (unknown), Ryo Konno, Yasuko Oguri, Miki Hashimura, (unknown), Mayu Nakagawa, (unknown), (unknown), Takashi Ito, Yoshio Kodera, Makoto Saegusa	7
12	Upregulation of fibronectin following loss of p53 function is a poor prognostic factor in ovarian carcinoma with a unique immunophenotype 2020 ·Cell Communication and Signaling ·Ako Yokoi, Toshihide Matsumoto, Yasuko Oguri, Yoshinori Hasegawa, (unknown), Mayu Nakagawa, Makoto Saegusa	12
13	S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma 2020 ·American Journal Of Pathology ·(unknown), Yasuko Oguri, Ako Yokoi, Toshihide Matsumoto, (unknown), (unknown), Miki Hashimura, (unknown), (unknown), Mayu Nakagawa, Makoto Saegusa	14
14	S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma 2019 ·Laboratory Investigation ·(unknown), Yasuko Oguri, Miki Hashimura, Ryo Konno, Toshihide Matsumoto, Ako Yokoi, Yoshio Kodera, Makoto Saegusa	28
15	Alterations in β-catenin, microsatellite instability, and HNF-1β levels are independently associated with ovarian endometriosis–associated tumorigenesis 2019 ·Human Pathology ·(unknown), Toshihide Matsumoto, (unknown), Yasuko Oguri, Ako Yokoi, (unknown), Makoto Saegusa	6
16	Nodal induces apoptosis and inhibits proliferation in ovarian endometriosis-clear cell carcinoma lesions 2019 ·BMC Cancer ·(unknown), Ako Yokoi, Toshihide Matsumoto, Yasuko Oguri, Miki Hashimura, (unknown), Sabine Kajita, Makoto Saegusa	5
17	TGF‐β‐mediated LEFTY/Akt/GSK‐3β/Snail axis modulates epithelial‐mesenchymal transition and cancer stem cell properties in ovarian clear cell carcinomas 2018 ·Molecular Carcinogenesis ·Toshihide Matsumoto, Ako Yokoi, Miki Hashimura, Yasuko Oguri, (unknown), Makoto Saegusa	44
18	A functional role of LEFTY during progesterone therapy for endometrial carcinoma 2017 ·Cell Communication and Signaling ·Fei Wu, (unknown), (unknown), Miki Hashimura, Yasuko Oguri, Sabine Kajita, Toshihide Matsumoto, Ako Yokoi, Makoto Saegusa	13
19	ALK signaling cascade confers multiple advantages to glioblastoma cells through neovascularization and cell proliferation 2017 ·PLoS ONE ·(unknown), (unknown), Miki Hashimura, Yasuko Oguri, Madoka Inukai, Atsuko Hara, Makoto Saegusa	23
20	Identification of LEFTY as a molecular marker for ovarian clear cell carcinoma 2017 ·Oncotarget ·(unknown), Masaaki Yamazaki, Toshihide Matsumoto, Yusuke Kawashima, Yasuko Oguri, Sabine Kajita, (unknown), (unknown), Ako Yokoi, Hiroyuki Takahashi, Yoshio Kodera, Makoto Saegusa	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact